EURO-E.W.I.N.G.99, NCT00020566: Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma |
|
|
| Unknown status | 3 | 1200 | Canada, US, RoW | dactinomycin, busulfan, doxorubicin hydrochloride, etoposide, ifosfamide, melphalan, vincristine sulfate, autologous hematopoietic stem cell transplantation, conventional surgery, radiation therapy | University of Leicester, National Cancer Institute (NCI), Children's Cancer and Leukaemia Group, Societe Francaise Oncologie Pediatrique, European Organisation for Research and Treatment of Cancer - EORTC, Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany, Gesellschaft fur Padiatrische Onkologie und Hamatologie - Austria, Swiss Group for Clinical Cancer Research, EBMT Solid Tumors Working Party, Children's Oncology Group | Sarcoma | 12/11 | | | |
| Completed | 3 | 907 | Europe | Zoledronic acid, Zometa, Bisphosphonate, Busulfan, Busilvex, Treosulfan | University Hospital Muenster | Ewing's Sarcoma | 03/19 | 03/19 | | |
| Completed | 3 | 278 | Europe | Standard treatment (as per protocol ISG SSG III), Vincristine, Dactinomycin, Doxorubicin, Ifosfamide, Cyclophosphamide, Etoposide, Busulfan, Melphalan, Intensified chemotherapy, Vincristine, | Italian Sarcoma Group | Ewing's Sarcoma | 04/22 | 04/22 | | |
